Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice

In people with type 1 diabetes, the immune system mistakenly identifies insulin-producing cells in the pancreas as foreign and attacks them, leaving the body unable to properly regulate blood sugar. While insulin therapy helps manage the disease, it does not stop the underlying immune attack.
This is a brief. The reporting belongs to Phys.org — read the complete story, with full context and credits, at the source.
Read the full story at Phys.org ↗phys.org
More from the Science desk
Just in

Water purification method turns old batteries into magnetic pollutant traps
Just in

How cells use alternative genetic instructions to produce 'shadowing proteins'
Just in

NASA Announces Mid-Power Electric Rocket Challenge for US Companies

Empire State Building Goes Gold for Voyager
